Phathom Pharmaceuticals's total assets for Q4 2024 were $378.32M, a decrease of -2.25% from the previous quarter. PHAT total liabilities were $631.90M for the fiscal quarter, a 10.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.